May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer? (Q38377310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

lip and oral cavity carcinoma

27 March 2020

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Bijayatha Shrestha

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Dipshikha Bajracharya

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Aditi Amit Byatnal

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

16 November 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

Pathology and Oncology Research

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

197-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

Matrix metalloproteinases

27 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

TIMPs as multifacial proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cells cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Control of matrix metalloproteinase catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Metalloproteinases and their inhibitors: influence on tumor invasiveness and metastasis formation in head and neck squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Tumour invasion and matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Regulation of membrane type-matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Linking DNA Damage and Hormone Signaling Pathways in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-016-0149-3

In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.

21 January 2018

1 reference

12 December 2020

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma

1 reference

12 December 2020

Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta

1 reference

12 December 2020

Gelatinase-mediated migration and invasion of cancer cells

1 reference

12 December 2020

Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.

1 reference

12 December 2020

Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study

1 reference

12 December 2020

Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma

1 reference

12 December 2020

Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma

1 reference

12 December 2020

Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization

1 reference

12 December 2020

Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma

1 reference

12 December 2020

Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas

1 reference

12 December 2020

Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential

1 reference

12 December 2020

92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro

1 reference

12 December 2020

The matrix metalloproteinase system in oral squamous cell carcinoma

1 reference

12 December 2020

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis

1 reference

12 December 2020

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis

1 reference

12 December 2020

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

1 reference

12 December 2020

Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model

1 reference

12 December 2020

Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis

1 reference

12 December 2020

Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.

1 reference

12 December 2020

Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity

1 reference

12 December 2020

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma

1 reference

12 December 2020

Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma

1 reference

12 December 2020

Tissue and circulating immunoreactive protein for MMP-2 and TIMP-2 in head and neck squamous cell carcinoma--tissue immunoreactivity predicts aggressive clinical course

1 reference

12 December 2020

Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue

1 reference

12 December 2020

High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma

1 reference

12 December 2020

Restricted expression of membrane type 1-matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells

1 reference

12 December 2020

10.1007/S12253-016-0149-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27853937%20AND%20SRC:MED&resulttype=core&format=json